Progenitor (PGEN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Progenitor (PGEN)

PGEN 4.160

+0.4%

Nov 3 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: chris dawson who wrote (17)	2/19/1998 1:44:00 PM
From: Czechsinthemail	Read Replies (1) of 106

I finally decided to buy in. My thought is that the stock price is cheap enough and the combination of partners, discoveries and patents looks strong enough to give the company some long term appeal. My concerns about the burn rate remain, though I think the company has a good chance to come up with new capital through new partnership agreements. Plus they will not be bearing the costs of clinicals. They will be in a good milestone and royalty position should any of their collaborations get to market. Does anyone have more detailed information on the people at PGEN or their research? Baird

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next